Doctor profile · Federal record

Dr. Emile Salloum, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Corpus Christi, TX

  • NPI 1144209024
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 41 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1625 Rodd Field RD, Suite 100
Corpus Christi, TX 784124926
(361) 887-0067
fax (361) 883-1484
Mailing address
Po Box 81346
Corpus Christi, TX 784681346

Credentials & registration

NPPES · NUCC
NPI registered
January 2006 — 20 yrs on file
Profile last updated
July 28, 2016
Year of graduation
1985 — 41 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Texas #K3846
Medicaid
TX #029575002

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1144209024. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
38,052
Distinct HCPCS
10
Medicare allowed
$1,376,025
HCPCS Description Services Patients Avg allowed
J9271 Injection, pembrolizumab, 1 mg 18,808 13 $54
J1100 Injection, dexamethasone sodium phosphate, 1 mg 6,616 54 $0
J2405 Injection, ondansetron hydrochloride, per 1 mg 4,509 55 $0
J0897 Injection, denosumab, 1 mg 3,060 14 $23
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 891 63 $27
96413 Administration of chemotherapy into vein, 1 hour or less 669 73 $121
J9190 Injection, fluorouracil, 500 mg 614 11 $2
99214 Established patient office or other outpatient visit, 30-39 minutes 377 196 $119
J9045 Injection, carboplatin, 50 mg 373 11 $2
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg 348 11 $139

In context: peer comparison

Among 2 peers in this city , average services per provider: 897. This provider delivers 42× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,721
Transactions
141
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 18 $514.98
E.R. Squibb & Sons, L.L.C. 16 $394.02
Merck Sharp & Dohme LLC 17 $369.52
Astellas Pharma US Inc 8 $340.49
PFIZER INC. 14 $313.04
Novartis Pharmaceuticals Corporation 15 $269.21
Daiichi Sankyo Inc. 8 $240.98
Stryker Corporation 1 $169.87
Celgene Corporation 9 $165.05
Eisai Inc. 7 $160.41
Janssen Biotech, Inc. 8 $154.09
Genentech USA, Inc. 7 $135.80
Ipsen Biopharmaceuticals, Inc 2 $134.13
Takeda Pharmaceuticals U.S.A., Inc. 7 $133.83
TAIHO ONCOLOGY, INC. 4 $118.97

By nature of payment

Food and Beverage
$4,233
Education
$488

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,824
Patients
491
Total drug cost
$3,731,641
Drug Type Claims Patients Total cost
Anastrozole Generic 589 140 $14,649
Tamoxifen Citrate Generic 225 60 $5,776
Letrozole Generic 224 43 $4,468
Ondansetron Hcl Generic 101 71 $966
Valacyclovir (Valacyclovir Hcl) Brand 97 23 $3,896
Dexamethasone Generic 87 38 $1,848
Ibrance (Palbociclib) Brand 78 11 $1,212,112
Pantoprazole Sodium Generic 69 18 $484
Prochlorperazine Maleate Generic 68 48 $1,648
Gabapentin Generic 62 16 $949

Frequently asked questions

Auto-generated from federal data
What is Dr. Emile Salloum's medical specialty?
Dr. Emile Salloum practices Hematology & Oncology Physician in Corpus Christi, TX.
Where does Dr. Emile Salloum practice?
Dr. Emile Salloum practices at 1625 Rodd Field RD, Corpus Christi, TX 784124926. Office phone: 3618870067.
What is Dr. Emile Salloum's NPI?
Dr. Emile Salloum's National Provider Identifier (NPI) is 1144209024, issued by NPPES.
Does Dr. Emile Salloum accept Medicare assignment?
Yes. Dr. Emile Salloum accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Emile Salloum commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100); Injection, ondansetron hydrochloride, per 1 mg (HCPCS J2405). Source: CMS Medicare Physician & Other Practitioners file.